San Diego, CA, United States of America

Laura Rodon

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Turning Point Therapeutics, Inc.. Active years: 2023.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Laura Rodon: Innovator in Cancer Treatment

Introduction

Laura Rodon is a prominent inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. With a focus on innovative therapies, she holds 2 patents that showcase her dedication to advancing medical science.

Latest Patents

Her latest patents include groundbreaking methods and compositions for treating cancer. One patent details a combination therapy involving diaryl macrocyclic compounds, which relates to the use of a diaryl macrocycle in conjunction with an inhibitor of MAPK/ERK kinase-1 and -2 (MEK1 and MEK2), such as trametinib. Another patent focuses on a similar combination therapy that utilizes a diaryl macrocycle alongside a KRAS inhibitor, specifically targeting KRAS G12C.

Career Highlights

Laura Rodon is currently associated with Turning Point Therapeutics, Inc., where she continues to develop innovative cancer therapies. Her work is characterized by a commitment to improving patient outcomes through novel treatment strategies.

Collaborations

Throughout her career, Laura has collaborated with esteemed colleagues, including Wei Deng and Dayong Zhai, contributing to a dynamic research environment that fosters innovation.

Conclusion

Laura Rodon's contributions to cancer treatment through her patents and collaborations highlight her role as a leading inventor in the medical field. Her work continues to inspire advancements in therapeutic strategies for cancer patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…